Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 10.59 License Agreement Between Bioxytran, Inc. and Pharmalectin, Inc. Dated May 5, 2020
- 10.60 License Agreement Between Pharmalectin, Inc. and NDPD Pharma, Inc. Dated May 2, 2021
- 10.61 2021 Employee, Director and Consultant Stock Plan, Adopted by the Board of Directors on January 19, 2021
- 10.62 2017 Employee, Director and Consultant Stock Plan (Subsidiary), Adopted by the Board of Directors on October 5, 2017
- 23.1 Consent of Independent Registered Public Accounting Firm
- Download Excel data file
- View Excel data file
Associated filings
- 22 Sep 22 RW Registration withdrawal request
- 21 Sep 22 RW WD Withdrawal of registration withdrawal request
- 28 Feb 22 RW Registration withdrawal request
- 26 Jul 21 424B4 Prospectus supplement with pricing info
- 26 Jul 21 424B4 Prospectus supplement with pricing info
- 26 Jul 21 EFFECT Notice of effectiveness
- 20 Jul 21 S-1/A IPO registration (amended)
-
24 Jun 21 S-1 IPO registration
BIXT similar filings
Filing view
External links
Exhibit 23.1
To Whom It May Concern:
We hereby consent to the incorporation of our report dated April 9, 2021, with respect to the financial statements of Bioxytran, Inc. for the years ended December 31, 2020 and 2019, included in the Registration Statement of Bioxytran, Inc. on Form S-1 to be filed on or about June 23, 2021. We also consent to the use of our name and the references to us included in the Registration Statement.
/s/ Pinnacle Accountancy Group of Utah
Pinnacle Accountancy Group of Utah
(a dba of Heaton & Company, PLLC)
Farmington, Utah
June 23, 2021